Hong Kong · Delayed Price · Currency is HKD Hangzhou Jiuyuan Genetic Biopharmaceutical Company Description
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally.
The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-G–CSF injection.
It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection.
The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
| Country | China |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,794 |
| CEO | Hang Fu |
Contact Details
Address: No. 23, Eighth Street Hangzhou China | |
| Phone | 86 57 1869 10099 |
| Website | china-gene.com |
Stock Details
| Ticker Symbol | 2566 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hang Fu | Executive Chairman and GM |
| Wei Zhou | Deputy GM, GM of Pharmacy Services and Executive Director |
| Yanmei Yang | Financial Controller |
| Hui Li | Deputy GM and Chief Manager of Manufacturing Center |
| Handong Sun | Deputy GM and Chief Manager of the Research and Development center |
| Xiu Huang | Joint Company Secretary |
| Wing Nga Ho P.E. | Joint Company Secretary |